Unique Ingredient Identifier 2PP9364507 is listed as a ingredient substance
RN | 182410-00-0 |
NCIT | C80913 |
RXCUI | 1426608 |
MF | C66H112O53S6.6Na |
INCHI KEY | VNDHXHMRJVTMTK-WZVRVNPQSA-H |
SMILES | [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@H](O[C@@H]3COCCCCS([O-])(=O)=O)O[C@H]4[C@H](O)[C@@H](O)[C@H](O[C@@H]4COCCCCS([O-])(=O)=O)O[C@H]5[C@H](O)[C@@H](O)[C@H](O[C@@H]5COCCCCS([O-])(=O)=O)O[C@H]6[C@H](O)[C@@H](O)[C@H](O[C@@H]6COCCCCS([O-])(=O)=O)O[C@H]7[C@H](O)[ |
UNII 2PP9364507 BETADEX SULFOBUTYL ETHER SODIUM is commonly included in medications in the following forms.
Route | Dosage Form | Potency |
---|---|---|
INTRAMUSCULAR | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH | 44.15 %W/V |
INTRAVENOUS | INJECTION | 25 % |
INTRAVENOUS | POWDER | 27 % |
INTRAVENOUS | POWDER, FOR INJECTION SOLUTION | 94.1 % |
INTRAVENOUS | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 96.23 % |
IV - SC | SOLUTION, INJECTION | 400 MG/ML |
IV(INFUSION) | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 16 % |